<code id='34F53B5DD5'></code><style id='34F53B5DD5'></style>
    • <acronym id='34F53B5DD5'></acronym>
      <center id='34F53B5DD5'><center id='34F53B5DD5'><tfoot id='34F53B5DD5'></tfoot></center><abbr id='34F53B5DD5'><dir id='34F53B5DD5'><tfoot id='34F53B5DD5'></tfoot><noframes id='34F53B5DD5'>

    • <optgroup id='34F53B5DD5'><strike id='34F53B5DD5'><sup id='34F53B5DD5'></sup></strike><code id='34F53B5DD5'></code></optgroup>
        1. <b id='34F53B5DD5'><label id='34F53B5DD5'><select id='34F53B5DD5'><dt id='34F53B5DD5'><span id='34F53B5DD5'></span></dt></select></label></b><u id='34F53B5DD5'></u>
          <i id='34F53B5DD5'><strike id='34F53B5DD5'><tt id='34F53B5DD5'><pre id='34F53B5DD5'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:1259
          Amedisys -- Hospital coverage from STAT
          Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

          Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

          Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

          advertisement

          But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more
          Readout LOUD podcast: A CRISPR milestone, biotech mixology
          Readout LOUD podcast: A CRISPR milestone, biotech mixology

          Whopolicesalgorithms?HowwouldyounamethefirstapprovedCRISPRmedicine?Andwhatpairswellwithabiotechdownt

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          With competition flaring, obesity drug hits goal in liver disease study

          AdobeLONDON—AdrugindevelopmentasaweightlosstreatmentsucceededinaPhase2studyinaseriouslivercondition,